Rockwell Medical Reports Q1 2025 Financial Results with $18.9M in Net Sales

Rockwell Medical, Inc. reported its financial results for the first quarter of 2025, revealing a net sales figure of $18.9 million, a decrease of 17% from $22.7 million in the same period last year. The company's cost of sales also declined by 19% to $15.9 million, resulting in a gross profit of $3.0 million, slightly down from $3.1 million in the prior year. The operating loss for the quarter was $1.4 million, compared to a loss of $1.3 million in the first quarter of 2024. The net loss for the period was $1.5 million, or $0.04 per share, an improvement from a net loss of $1.7 million, or $0.06 per share, in the previous year.

In terms of operational changes, Rockwell Medical has been actively managing its costs, with selling and marketing expenses increasing by 20% to $711,000, while general and administrative expenses decreased slightly to $3.7 million. The company has also made strategic moves to enhance its product offerings, including a distribution services agreement with a leading medical equipment manufacturer, which allows Rockwell to distribute a new single-use bicarbonate cartridge. This product is FDA-approved and is expected to expand Rockwell's market presence in the hemodialysis sector.

The company’s balance sheet as of March 31, 2025, showed total assets of $54.0 million, down from $59.2 million at the end of 2024. Cash and cash equivalents decreased to $11.4 million from $15.7 million, while accounts receivable increased to $9.7 million from $8.3 million. Total liabilities also decreased to $22.4 million from $26.6 million, reflecting a reduction in accrued liabilities and accounts payable. The company’s stockholders' equity stood at $31.5 million, down from $32.6 million at the end of the previous fiscal year.

Looking ahead, Rockwell Medical is focused on maintaining sufficient liquidity to support its operations, with approximately $17.3 million in cash, cash equivalents, and investments available for sale. The company is exploring additional capital-raising opportunities, including utilizing its at-the-market facility, which has $21.1 million available. However, management has acknowledged the potential challenges posed by the current macroeconomic environment, including inflationary pressures and geopolitical instability, which could impact future operations and financial performance. The company remains committed to executing its strategic plan while navigating these uncertainties.